EBS Law Term 2013 Intellectual Property Law Patent Law: Introduction Prof. Martin Senftleben VU...
-
Upload
eugene-conrad-clark -
Category
Documents
-
view
217 -
download
1
Transcript of EBS Law Term 2013 Intellectual Property Law Patent Law: Introduction Prof. Martin Senftleben VU...
EBS Law Term 2013 Intellectual Property Law
Patent Law: Introduction
Prof. Martin SenftlebenVU University Amsterdam
Bird & Bird, The Hague
Intellectual property domains
technology
commerce
culture
patent law
trademark law
copyright law
Contents
• definition
• international treaties
• criteria of protection
• exclusions from patentability
Definition
A patent is an exclusive right in an industrial
invention that is granted upon request
... great inventions:
• penicillin
• transistor
... small inventions:
• post-it stickers
• Lego bricks
International treaties
International
• WIPO: The Paris Convention for the
Protection of Industrial Property
(1886/1967)
• WTO: The Agreement on Trade-Related
Aspects of Intellectual Property Rights
(1994)
• WIPO: The Patent Cooperation Treaty
(PCT, 1970)
Criteria of protection
Art. 27(1) of the TRIPS Agreement
‘...patents shall be available for any
inventions, whether products or
processes, in all fields of technology,
provided that they are
• new,
• involve an inventive step and
• are capable of industrial application.’
Novelty
Subject matter is not new if it belongs to
the state of the art.
... to determine on the basis of the situation at
• the filing date (when applying for a patent for
the first time)
• the priority date (when subsequently filing
patent applications in further countries of the
Paris Union)
Paris Union
filing a patent application in one
country of the Union
12 months
subsequent filings in
other Union countries
Priority right (art. 4 of the Paris Convention)
State of the art
= everything that is made publicly available
• decisive: can a person skilled in the art
carry out the invention on the basis of the
information made available?
• essential: keeping the invention secret
before applying for a patent
(protection of trade secrets via unfair
competition law (see art. 39 TRIPS))
Still new?
• publications in foreign languages
• earlier, not yet published patent applications
• talks, presentations, product proofs
• demonstration to visitors
... (-)
• demonstration at official or officially recognized international exhibitions
... (+) because of temporary protection granted under art. 11 Paris Convention
Inventive step
...when the invention is non-obvious for a
person skilled in the art.
... to determine on the basis of the situation at
• the filing date (first application)
• the priority date (subsequent applications in
countries of the Paris Union)
The person skilled in the art
• artificial, objective standard
• (average) specialist
– has working experience in the relevant field
of technology
– has standard knowledge
– knows the specific, relevant state of the art
In practice
• contents of patent claims
– not new if all elements can be found in one single prior source (mostly earlier patent or earlier patent application);
– not inventive if all elements can be derived from several prior sources, the combination of which is obvious.
• from the perspective of a person skilled in the art, considering that person’s standard knowledge
Industrial application
...when the subject matter can be applied
to any field of industry.
• Industry is to be understood in a broad
sense, including not only ‘industry and
commerce proper’ but also ‘agricultural
and extractive industries’
(art. 1(3) of the Paris
Convention).
The field of industry
‘Industrial property shall be understood in the
broadest sense and shall apply not only to
industry and commerce proper, but likewise to
agricultural and extractive industries and to all
manufactured or natural products, for example,
wines, grain, tobacco leaf, fruit, cattle, minerals,
mineral waters, beer, flowers, and flour.’
(art. 1(3) of the Paris Convention)
Exclusions from patentability
Art. 27(2) of the TRIPS Agreement
Inventions may be excluded if this is necessary to
• protect the ordre public or morality;
• protect human, animal or plant life or health;
• avoid serious prejudice to the environment.
Art. 27(3) of the TRIPS Agreement
Members may also exclude
• diagnostic, therapeutic and surgical methods for the treatment of humans or animals;
• plants and animals other than micro-organisms, and essentially biological processes for the production of plants or animals other than non-biological and microbiological processes.
engine of innovation
ethical questions
developing countries: biodiversity
Discussion on biotech inventions
• US: Diamond vs. Chakrabarty,
447 U.S. 303 (1980)
• lead of the US and Japan over the EU
• EU: Biotech Directive 98/44/EC (1998)
Art. 3 EC Biotech Directive
• ‘... inventions ... shall be patentable even
if they concern a product consisting
of or containing biological material or a
process by means of which biological
material is produced, processed or used.’
• ‘Biological material which is isolated from its
natural environment or produced by means
of a technical process may be the subject of
an invention even if it previously occurred in
nature.’
EBS Law Term 2013 Intellectual Property Law
Patent Law: Acquisition
Prof. Martin SenftlebenVU University Amsterdam
Bird & Bird, The Hague
Contents
• registration procedure
• term of protection
• registration strategies
• portfolio management
Registration procedure
Examination systems
applicationformal
substantivea. novelty
b. further requirements
refusal
grant oppositionexamination
Registration systems
applicationformal
substantivea. novelty
b. further requirements
refusal
grant oppositionexamination
( )
( )
Pros and cons
Examination system
• legal certainty high
• long procedure
• expensive
• settlement of
disputes in the
framework of the
office procedure
Registration system
• legal certainty low
• short procedure
• cheap
• settlement of
disputes in court
proceedings
Term of protection
The term of protection
• ‘The term of protection available shall not
end before the expiration of a period of
twenty years counted from the filing date.’
(art. 33 TRIPS)
• extensions in certain technical fields?
– pharmaceutical products requiring marketing
approval (can take several years)
– supplementary protection certificates in certain
countries (example: EU)
Registration strategies
filing a patent application in one
country of the Union
12 months
subsequent filings in
other Union countries
Starting point: priority right (art. 4 PC)
national registrations
regional: European Patent Convention (EPC)
bundle of rights having the same effect as national
patents
Different routes of registration
Patent Cooperation Treaty (PCT): international registration
International route: Patent Cooperation Treaty
Local patent application followed within 12 months by multiple foreign applications claiming priority under Paris Convention:
- multiple formality requirements
- multiple searches
- multiple publications
- multiple examinations and prosecutions of applications
- translations and national fees required at 12 months
Some rationalization because of regional arrangements: ARIPO, EAPO, EPO, OAPI
0 12
Fileapplication
locally
Fileapplications
abroad
(months)
Starting point: traditional system
(months)
File PCTapplication
120 30
International search report
& written opinion
16 18
Internationalpublication
(optional)File
demand forInternational preliminary examination
File localapplication
Enternationalphase
22 28
(optional)International preliminary report on
patentability
Typically a national patent application in the home country of
the applicant
What is the PCT?
Overview PCT system
(months)
File PCTapplication
120 30
International search report
& written opinion
16 18
Internationalpublication
(optional)File
demand forinternational preliminary examination
File localapplication
Enternationalphase
22 28
(optional)International preliminary report on
patentabilityTypically filed in same
national patent office--one set of fees, one language,
one set of formality requirements--and legal effect in all PCT States:
effect international application = national
patent application
What is the PCT?
Overview PCT system
(months)
File PCTapplication
120 30
International search report
& written opinion
16 18
Internationalpublication
(optional)File
demand forInternational preliminary examination
File localapplication
Enternationalphase
22 28
(optional)International preliminary report on
patentability
Report on state of the art (prior art documents and their relevance) + initial, non-binding patentability
opinion:
applicant can evaluate the application
What is the PCT?
Overview PCT system
(months)
File PCTapplication
120 30
International search report
& written opinion
16 18
Internationalpublication
(optional)File
demand forInternational preliminary examination
File localapplication
Enternationalphase
22 28
(optional)International preliminary report on
patentability
Disclosing to world content of application in standardized way
What is the PCT?
Overview PCT system
(months)
File PCTapplication
120 30
International search report
& written opinion
16 18
Internationalpublication
(optional)File
demand forinternational preliminary examination
File localapplication
Enternationalphase
22 28
(optional)International preliminary report on
patentability
Request an additional patentability analysis on basis
of amended application
What is the PCT?
Overview PCT system
(months)
File PCTapplication
120 30
International search report
& written opinion
16 18
Internationalpublication
(optional)File
demand forinternational preliminary examination
File localapplication
Enternationalphase
22 28
(optional)International preliminary report on
patentability
Additional patentability analysis, designed to assist in national phase decision-
making:
again a preliminary, non-binding opinion
What is the PCT?
Overview PCT system
(months)
File PCTapplication
120 30
International search report
& written opinion
16 18
Internationalpublication
(optional)File
demand forinternational preliminary examination
File localapplication
Enternationalphase
22 28
(optional)International preliminary report on
patentability
Express intention and take steps to pursue to grant in
various states
What is the PCT?
Overview PCT system
Fees for:
--translations--Office fees--local agents
0 12
File local application
Fileapplications
abroad(months)
Traditional
(months)
File PCTapplication
12 30
International search report & written opinion
16 18
Internationalpublication
(optional)File
demand forinternational preliminary examination
File localapplication
Enternationalphase
22 28
(optional)International preliminary report on
patentability
PCT
0
Fees for:
--translations--Office fees--local agents
Why use the PCT?
Comparison of the systems
Success of the PCT system
• more time for decision making:
30 instead of 12 months
• PCT form accepted by any Contracting
Party = no rejection on formal grounds
• evaluation and amendment of the
invention prior to national phase
• major costs of filing in different countries
are postponed
EBS Law Term 2013 Intellectual Property Law
Patent Law: Protection
Prof. Martin SenftlebenVU University Amsterdam
Bird & Bird, The Hague
Contents
• exclusive rights
• exceptions
• other use without authorization
Exclusive rights
Art. 28(1) of the TRIPS Agreement
‘A patent shall confer on its owner the
following exclusive rights:
a.where the subject matter of a patent is a
product, to prevent third parties […] from
the acts of: making, using, offering for
sale, selling, or importing for these
purposes that product;…’
Art. 28(1) of the TRIPS Agreement
b.where the subject matter of a patent is a
process, to prevent third parties […] from
the act of using the process, and from the
acts of: using, offering for sale, selling, or
importing for these purposes at least the
product obtained directly by that process.’
Problem 1: identical product may be obtained with a different process
process A
process D
process B
process C
Art. 34(1) of the TRIPS Agreement
‘…if the subject matter of a patent is a process
for obtaining a product, the judicial authorities
shall have the authority to order the defendant
to prove that the process to obtain an identical
product is different from the patented process.
Therefore, Members shall provide, in at least
one of the following circumstances, that any
identical product when produced without the
consent of the patent owner shall, in the
absence of proof to the contrary,…’
Art. 34(1) of the TRIPS Agreement
‘…be deemed to have been obtained by
the patented process:
a. if the product obtained by the patented
process is new;
b. if there is a substantial likelihood that the
identical product was made by the process
and the owner of the patent has been unable
through reasonable efforts to determine the
process actually used.’
Art. 34(3) of the TRIPS Agreement
‘In the adduction of proof to the contrary,
the legitimate interests of defendants in
protecting their manufacturing and
business secrets shall be taken into
account.’
Problem 2: further products may be required to obtain the final product
father mother son final
production of compact discs
A is holder of a UK
process patent for the
production of ‘father’ discs
at a particular pressure.
He wants to prevent B
from importing final discs.
B uses the patented
process in China to obtain
father discs and carry out
the further production
steps. He offers the final
discs in the UK.
Process patent infringement? (UK: Pioneer Electronics vs. Warner Music)
father mother son final
production of compact discs
Art. 28(1) of the TRIPS Agreement
b.where the subject matter of a patent is a
process, to prevent third parties […] from the
act of using the process, and from the acts
of: using, offering for sale, selling, or
importing for these purposes at least the
product obtained directly by that process.’
• answer depends on national interpretation of
‘obtaining directly’
Exceptions
Art. 30 of the TRIPS Agreement
‘Members may provide for limited exceptions
to the exclusive rights conferred by a patent,
provided that such exceptions do not
unreasonably conflict with a normal
exploitation of the patent and do not
unreasonably prejudice the legitimate
interests of the patent owner, taking account
of the legitimate interests of third parties.’
expiry
generic version
protected medicine
• exempts use of the patented invention for
tests necessary to obtain marketing
approval for pharmaceutical products
• US: Roche Products vs. Bolar Pharma
Example: ‘Bolar’ exception
Example: experimental use
‘The rights conferred by a Community Patent shall not extend to: [...] acts done for experimental purposes relating to the subject-matter of the patented invention.’ (art. 27(b) Community Patent Convention)
• testing claimed properties or different indications (+)
• ...insofar as the experiments are directed to the substance itself
• use for commercial research?
Other use without authorization
Art. 31 of the TRIPS Agreement
• problem of compulsory licenses
• detailed list of requirements, such as
– efforts to obtain regular authorization
– national emergency
– limited scope and duration according to purpose
– non-exclusive, non-assignable
– predominantly for the domestic market
– payment of adequate remuneration
– judicial review
Problem: flexible enough for sufficient access to medicine?
• ‘national
emergency’?
• ‘predominantly
for the
domestic
market’?
Art. 31(l) of the TRIPS Agreement
• problem of later patents involving an important
technical advance of considerable economic
significance in relation to the prior invention
• specific requirements
– cross-license on reasonable terms for the owner of
the first patent
– use authorization with regard to the first patent is
non-assignable except with the assignment of the
second patent
Problem: flexible enough for markets with small, incremental innovative steps?
• ‘important
technical
advance’?
• ‘considerable
economic
significance’?
The end.
contact: [email protected]
ANNEX: Interpretation of
Patent Claims
Interpretation of Patent Claims
• central elements of a patent application:
– claims
– description, drawings
• different approaches to interpretation:
– literal (wording of the claims)
– teleological (core of the inventive idea)
• additional consideration: equivalents
the same function
in the same way with
the same results
Equivalents
doctrine (+)
no need to specify
each and every
variant of the
invention in the
specification
doctrine (-)
more detailed
claims advisable to
close potential
loopholes for
competitors
Impact in practice
Different approaches in countries of the European Patent Convention
• ‘Epilady’ saga (1990-1993)
• plaintiff
– holds patent rights to ‘Epilady’, a gadget for
removing body hair with a coiled spring
• defendant
– applies same inventive idea
– but: uses a rubber tube instead of the coiled
spring
• DE and NL: infringement (+)
• UK: infringement (-)
UK approach: three questions
• variant having material effect upon the way
the invention works?
– if yes, infringement (-)
• if no: absence of material effect obvious at
the date of patent publication?
– if no, infringement (-)
• if yes: claim indicating that strict compliance
with the primary meaning of the terms
essential to the invention?
– if yes, infringement (-)
UK approach: three questions
• inherent problem: last question takes the
court back to interpretation
• critique led to departure from the test
– Kirin-Amgen vs. Hoechst Marion Roussel,
[2005] RPC (9), 169
– no mechanical application, in particular less
helpful in case of complex chemical or
biotechnological inventions
– example: claim to a whole group of chemical
compounds expected to have similar
characteristics